{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:11:43Z","timestamp":1788873103966,"version":"build-2803163510"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The British National Formulary and the NICE provide empirical treatment guidance for the management of various infections, including recommendations on antibiotic doses. In parallel, and for over 15\u2005years, EUCAST has published details of the doses upon which their antimicrobial susceptibility breakpoints are predicated, termed here \u2018breakpoint-defining doses\u2019. Recently, differences between these dosing recommendations have attracted attention, particularly since EUCAST introduced its \u2018susceptible, increased exposure\u2019 category of susceptibility. We discuss where and why these differences exist and how to reconcile them.<\/jats:p>","DOI":"10.1093\/jac\/dkag315","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:15:02Z","timestamp":1788520502000},"source":"Crossref","is-referenced-by-count":0,"title":["Reconciling differences between EUCAST \u2018breakpoint-defining doses\u2019 and UK national antimicrobial treatment guidelines"],"prefix":"10.1093","volume":"81","author":[{"given":"Conor","family":"Jamieson","sequence":"first","affiliation":[{"name":"Medical Directorate, NHS England (Midlands) , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-5263","authenticated-orcid":false,"given":"Sara E","family":"Boyd","sequence":"additional","affiliation":[{"name":"David Price Evans Global Health and Infectious Disease Research Group, University of Liverpool, Institute of Systems, Molecular & Integrative Biology , William Henry Duncan Building, Liverpool L7 8TX ,","place":["UK"]},{"name":"Infection Clinical Academic Group, St. George\u2019s Hospital NHS Foundation Trust , Blackshaw Road, London SW17 0QT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2227-3355","authenticated-orcid":false,"given":"Mandy","family":"Wootton","sequence":"additional","affiliation":[{"name":"Specialist Antimicrobial Chemotherapy Unit, Public Health Wales, University Hospital of Wales , Cardiff ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Livermore","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Floor 2, Bob Champion Research & Educational Building, James Watson Road, Norwich NR4 7UQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Hand","sequence":"additional","affiliation":[{"name":"Medical Directorate, NHS England , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair P","family":"Macgowan","sequence":"additional","affiliation":[{"name":"Antimicrobial Reference Laboratory, North Bristol NHS Trust , Westbury-on Trym, Bristol ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A","family":"Howe","sequence":"additional","affiliation":[{"name":"Specialist Antimicrobial Chemotherapy Unit, Public Health Wales, University Hospital of Wales , Cardiff ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"BSAC Standing Committee on Antimicrobial Susceptibility Testing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipa","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Hafezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lim","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Livermore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Macgowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairi","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Teale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Wootton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2026090808571752100_dkag315-B1","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2026090808571752100_dkag315-B2","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2026090808571752100_dkag315-B3","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1111\/j.1469-0691.2011.03752.x","article-title":"The role of pharmacokinetics\/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach","volume":"18","author":"Mouton","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2026090808571752100_dkag315-B4","author":"EUCAST"},{"key":"2026090808571752100_dkag315-B5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmi.2016.11.013","article-title":"Amoxicillin dosing recommendations are very different in European countries: a cross-sectional survey","volume":"23","author":"Pulcini","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2026090808571752100_dkag315-B6","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/937861","article-title":"Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection","volume":"2011","author":"Huth","year":"2011","journal-title":"Int J Otolaryngol"},{"key":"2026090808571752100_dkag315-B7","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/10\/dkag315\/70993884\/dkag315.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/10\/dkag315\/70993884\/dkag315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:57:25Z","timestamp":1788872245000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag315\/8787871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag315","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"dkag315"}}